Supernus Pharmaceuticals, Inc. - Common Stock (NQ:SUPN)
Price and Volume
Detailed Quote| Volume | 0 |
| Open | 42.81 |
| Bid (Size) | 42.01 (100) |
| Ask (Size) | 43.50 (100) |
| Prev. Close | 42.81 |
| Today's Range | 42.81 - 42.81 |
| 52wk Range | 40.51 - 59.68 |
| Shares Outstanding | 53,145,884 |
| Dividend Yield | N/A |
Top News
More News
Performance
52-Week Range
28.3% below 52-week high
42.81
40.5152W Low
59.6852W High
1 Week
1.4% below 1-week high
41.131W Low
43.411W High
Supernus Pharmaceuticals, Inc. - Common Stock (SUPN) traded between $40.51 and $59.68 over the past 52 weeks and last traded at $42.81, 28.3% below its 52-week high. Over the past week it ranged between $41.13 and $43.41.
Past 12 Months
1W
-$0.02
1M
+$1.32
3M
-$4.54
6M
-$7.14
YTD
-$6.66
1Y
-$5.57
SUPN was -11.5% over the past year, -14.3% over six months, -13.5% year to date, -0.0% in the last week.
12 Months vs Market
SUPN
-11.5%
DIA
+12.4%
SPY
+17.4%
QQQ
+23.9%
IWM
+13.7%
Over the past 12 months SUPN returned -11.5% versus DIA (Dow) +12.4%, SPY (S&P 500) +17.4%, QQQ (Nasdaq 100) +23.9% and IWM (Russell 2000) +13.7%.
Volume & Liquidity
1W
712.4K
1M
709.8K
3M
752.5K
6M
757.1K
YTD
744.2K
1Y
760.5K
SUPN's 3-month average daily volume is 752.5K.
More News
Read More
2 Growth Stocks to Add to Your Roster and 1 We Question
September 28, 2026
3 Reasons SUPN is Risky and 1 Stock to Buy Instead
September 21, 2026
3 Cash-Heavy Stocks Walking a Fine Line
September 16, 2026
Supernus Pharmaceuticals to Participate in September Investor Conferences
September 02, 2026
3 Out-of-Favor Stocks We’re Skeptical Of
September 02, 2026
3 Small-Cap Stocks with Open Questions
August 25, 2026
1 Healthcare Stock with Exciting Potential and 2 We Ignore
August 18, 2026
3 Russell 2000 Stocks We Approach with Caution
August 14, 2026
Why Supernus Pharmaceuticals Stock Topped the Market Today ↗
August 03, 2026
Supernus Pharmaceuticals Q2 Earnings Call Highlights ↗
August 03, 2026
What's going on in today's pre-market session ↗
August 03, 2026
Supernus Announces Second Quarter 2026 Financial Results
August 03, 2026
Frequently Asked Questions
Is Supernus Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Supernus Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Supernus Pharmaceuticals, Inc. - Common Stock trade on?
Supernus Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Supernus Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Supernus Pharmaceuticals, Inc. - Common Stock is SUPN on the Nasdaq Stock Market
What is the current price of Supernus Pharmaceuticals, Inc. - Common Stock?
The current price of Supernus Pharmaceuticals, Inc. - Common Stock is 42.81
When was Supernus Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Supernus Pharmaceuticals, Inc. - Common Stock was at 10/12/26 04:00 PM ET
What is the market capitalization of Supernus Pharmaceuticals, Inc. - Common Stock?
The market capitalization of Supernus Pharmaceuticals, Inc. - Common Stock is 2.28B
How many shares of Supernus Pharmaceuticals, Inc. - Common Stock are outstanding?
Supernus Pharmaceuticals, Inc. - Common Stock has 2B shares outstanding.